Table Of Contents
1 Introduction 18
1.1 Objectives Of The Study 18
1.2 Market Definition 18
1.3 Overview Of Middle East And Africa Clinical Trial Supplies Market 19
1.4 Currency And Pricing 20
1.5 Limitation 20
1.6 Markets Covered 21
2 Market Segmentation 23
2.1 Markets Covered 23
2.2 Geographic Scope 24
2.3 Years Considered For The Study 25
2.4 Currency And Pricing 25
2.5 Research Methodology 26
2.6 Primary Interviews With Key Opinion Leaders 29
2.7 DBMR Market Challenge Matrix 30
2.8 Secondary Sources 31
2.9 Assumptions 31
3 Market Overview 32
3.1 Drivers 34
3.1.1 Rising Demand Of Clinical Trials Worldwide 34
3.1.2 Increasing Incidences Of Diseases 35
3.1.3 Government Funds To R&D Investments 36
3.1.4 Development Of New Treatments Such As Personalized Medicine 36
3.2 Restraints 37
3.2.1 Adverse Effects Of Clinical Trials 37
3.2.2 Transportation Issue 37
3.3 Opportunities 38
3.3.1 New Drug Development And Availability In Emerging Countrires 38
3.4 Challenges 39
3.4.1 Longer Procedure Time Of Clinical Trials Approval 39
4 Executive Summary 40
5 Premium Insights 42
6 Middle East And Africa Clinical Trial Supplies Market, By Services 44
6.1 Overview 45
6.2 Storage 47
6.3 Manufacturing 49
6.4 Packaging And Labeling 50
6.5 Distribution 52
7 Middle East And Africa Clinical Trial Supplies Market, By Clinical Phases 53
7.1 Overview 54
7.2 Phase Iii 56
7.3 Phase Ii 57
7.4 Phase Iv 58
7.5 Phase I 59
8 Mjkmiddle East And Africa Clinical Trial Supplies Market, By Therapeutic Use 61
8.1 Overview 62
8.2 Oncology 64
8.3 Cardiovascular Disease 66
8.4 Dermatology 67
8.5 Metabolic Disorders 68
8.6 Infectious Disease 69
8.7 Respiratory Diseases 70
8.8 Cns And Mental Disorders 71
8.9 Blood Disorders 72
8.10 Others 73
9 Middle East And Africa Clinical Trial Supplies Market, By End User 74
9.1 Overview 75
9.2 Contract Research Organizations 77
9.3 Pharmaceutical And Biotechnology Companies 78
10 Middle East And Africa Clinical Trial Supplies Market, By Geography 80
10.1 Middle East & Africa 80
10.1.1 South Africa 87
10.1.2 Egypt
10.1.3 Saudi Arabia
10.1.4 United Arab Emirates
10.1.5 Israel
10.1.6 Rest Of Middle East & Africa 89
11 Middle East And Africa Clinical Trial Supplies Market, Company Landscape 90
11.1 Company Share Analysis; Middle East And Africa 90
12 Company Profile 91
12.1 Thermo Fisher Scientific Inc. 91
12.1.1 Company Overview 91
12.1.2 Revenue Analysis 91
12.1.3 Company Share Analysis 92
12.1.4 Product Portfolio 92
12.1.5 Recent Developments 93
12.2 Catalent, Inc.94
12.2.1 Company Overview 94
12.2.2 Revenue Analysis 94
12.2.3 Company Share Analysis 95
12.2.4 Product Portfolio 95
12.2.5 Recent Developments 96
12.3 Clinigen Group Plc. 97
12.3.1 Company Overview 97
12.3.2 Revenue Analysis 97
12.3.3 Revenue Analysis 98
12.3.4 Product Portfolio 98
12.3.5 Recent Developments 98
12.4 Parexel International Corporation 99
12.4.1 Company Overview 99
12.4.2 Revenue Analysis 99
12.4.3 Company Share Analysis 100
12.4.4 Product Portfolio 100
12.4.5 Recent Developments 100
12.5 Alium Medical Limited 101
12.5.1 Company Overview 101
12.5.2 Product Portfolio 101
12.5.3 Recent Developments 101
12.6 Almac Group 102
12.6.1 Company Overview 102
12.6.2 Geographic Presence 102
12.6.3 Product Portfolio 103
12.6.4 Recent Developments 103
12.7 Ancillare, Lp 104
12.7.1 Company Overview 104
12.7.2 Geographic Presence 104
12.7.3 Product Portfolio 105
12.7.4 Recent Developments 105
12.8 Biocair 106
12.8.1 Company Overview 106
12.8.2 Product Portfolio 106
12.8.3 Recent Developments 106
12.9 Bionical Ltd. 107
12.9.1 Company Overview 107
12.9.2 Gepographic Presence 107
12.9.3 Product Portfolio 108
12.9.4 Recent Developments 108
12.10 Clinical Supplies Management Holdings, Inc. 109
12.10.1 Company Overview 109
12.10.2 Geographic Presence 109
12.10.3 Product Portfolio 110
12.10.4 Recent Developments 110
12.11 Klifo 111
12.11.1 Company Overview 111
12.11.2 Geographic Presence 111
12.11.3 Product Portfolio 112
12.11.4 Recent Developments 112
12.12 Movianto 113
12.12.1 Company Overview 113
12.12.2 Geographic Presence 113
12.12.3 Product Portfolio 114
12.12.4 Recent Developments 114
12.13 Myoderm 115
12.13.1 Company Overview 115
12.13.2 Geographic Presence 115
12.13.3 Product Portfolio 116
12.13.4 Recent Developments 116
12.14 Pci Pharma Services 117
12.14.1 Company Overview 117
12.14.2 Geographic Presence 117
12.14.3 Product Portfolio 118
12.14.4 Recent Developments 118
12.15 Sharp 119
12.15.1 Company Overview 119
12.15.2 Geographic Presence 119
12.15.3 Product Portfolio 120
12.15.4 Recent Developments 121
12.16 Siro Clinpharm 122
12.16.1 Company Overview 122
12.16.2 Geographic Presence 122
12.16.3 Product Portfolio 123
12.16.4 Recent Developments 123
13 Related Reports 124
?
Li